Amniotic Products Market - Global Size, Share, Trend Analysis, Opportunity and Forecast Report, 2019-2030, Segmented By Type ; By End User ; By Application ; By Region

Description

Global Amniotic Products Market Size Set to Surpass USD 1.3 Billion by 2030, Expanding at CAGR of 8.56% During 2024-2030.

Global Amniotic Products Market is gaining traction because of the growing awareness about the benefits of amniotic products and increasing investments in amniotic product research and development.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Amniotic Products Market size at USD 810.4 million in 2023. During the forecast period between 2024 and 2030, BlueWeave expects the Global Amniotic Products Market size to grow at a CAGR of 8.56% reaching a value of USD 1,326.2 million by 2030. The increasing use of amniotic products in the treatment of skin and eye conditions, as well as the growing incidence of chronic wounds, such as ulcers, are significant driving factors for the Global Amniotic Products Market. Moreover, over the period in analysis, it is expected that growing number of research and development programs on amniotic products will propel market growth.

Opportunity: Increasing number of amniotic product launches

The rising adoption of amniotic products in the healthcare sector owing to their therapeutic properties is also influencing product launches and research and development programs in the field. For instance, Amnio Technology, a United States-based developer and manufacturer of amnion-derived technologies, announced the launch of two new PalinGen membrane products, PalinGen Dual-Layer Membrane, and Dual Layer PalinGen X-Membrane. Versea Health, Inc., another US-based pharmaceutical products company, is launching Biovance 3L ocular tri-layer human amniotic membrane.

Global Amniotic Products Market - By End User

Based on end user, the Global Amniotic Products Market is segmented into hospitals, ambulatory surgical centers, and others. The hospital segment holds the largest share of the Global Amniotic Products Market by end user. The growth of the segment is mainly attributed to the high number of outpatient visits for wound treatment and surgical procedures. Amniotic membranes are mostly obtained at hospitals for use in tendon and ligament repair or for ophthalmic purposes. Hospital billing and reimbursement for these products are also easily obtained, which is a key factor contributing to the growth of the hospitals segment.

Impact of Escalating Geopolitical Tensions on Global Amniotic Products Market

The escalating geopolitical tensions are negatively impacting the growth of the Global Amniotic Products Market. Ukraine has a flourishing medical tourism sector. The country offers cost-effective quality healthcare. Ukraine's medical sector was increasingly becoming the hub for specialized treatments not readily available in other countries. However, with Russia's war on Ukraine, medical tourism dwindled, and the number of surgeries performed in the country declined at a staggering rate owing to the sensitive situation in the country and a lack of resources. It resulted in a significant decline in the demand for amniotic products for healthcare purposes as well as hindered research and development activities, limiting its market growth.

Global Amniotic Products Market - By Region

The in-depth research report on the Global Amniotic Products Market covers a number of country-specific markets across five major regions: North America, Europe, Asia Pacific (APAC), Latin America, and Middle East and Africa. North America dominates the Global Amniotic Products Market. The rising healthcare expenditure, coupled with the increasing prevalence of chronic wounds and diabetes, as well as the high concentration of amniotic product manufacturers, are directly influencing market growth. However, the Asia Pacific region is projected to register a high growth rate during the forecast period owing to the growing geriatric population in East Asian countries, including Japan and South Korea.

Competitive Landscape

Major players operating in the Global Amniotic Products Market include: MiMedx Group, Organogenesis, Smith & Nephew, Integra LifeSciences, Amniox Medical, AmnioTech, Skye Biologics, Applied Biologics, TissueTech, and Katena Products. These companies employ various strategies to further enhance their market share, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

Don't miss the business opportunity in the Global Amniotic Products Market. Consult our analysts to gain crucial insights and facilitate your business growth.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and the Global Amniotic Products Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in the Global Amniotic Products Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Product Code: BWC24030

1. Research Framework

1.1. Research Objective
1.2. Product Overview
1.3. Market Segmentation

2. Executive Summary

3. Global Amniotic Products Market Insights

3.1. Industry Value Chain Analysis
3.2. DROC Analysis
- 3.2.1. Growth Drivers
  - 3.2.1.1. Increasing Prevalence of Chronic Wounds
  - 3.2.1.2. Growing Awareness of the Benefits of Amniotic Products
  - 3.2.1.3. Increasing Investments in Amniotic Product Research and Development
- 3.2.2. Restraints
  - 3.2.2.1. Limited Availability of Amniotic Membranes
  - 3.2.2.2. Competition from Alternative Wound Care Products
- 3.2.3. Opportunities
  - 3.2.3.1. Expanding Applications in Regenerative Medicine
  - 3.2.3.2. Growing Demand in Emerging Markets
- 3.2.4. Challenges
  - 3.2.4.1. Maintaining the Quality and Consistency of Amniotic Products
  - 3.2.4.2. Educating Healthcare Professionals about Amniotic Products
3.3. Technological Advancements/Recent Developments
3.4. Consumer Behavior and Insights
3.5. Regulatory Framework
3.6. Porter's Five Forces Analysis
- 3.6.1. Bargaining Power of Suppliers
- 3.6.2. Bargaining Power of Buyers
- 3.6.3. Threat of New Entrants
- 3.6.4. Threat of Substitutes
- 3.6.5. Intensity of Rivalry

4. Global Amniotic Products Market Overview

4.1. Market Size & Forecast, 2019-2030
- 4.1.1. By Value (USD Million)
4.2. Market Share and Forecast
- 4.2.1. By Type
  - 4.2.1.1. Cryopreserved Amniotic Membrane
  - 4.2.1.2. Dehydrated Amniotic Membrane
- 4.2.2. By End User
  - 4.2.2.1. Hospitals & Ambulatory Surgical Centers
  - 4.2.2.2. Others
- 4.2.3. By Application
  - 4.2.3.1. Wound Care
  - 4.2.3.2. Orthopedics
  - 4.2.3.3. Ophthalmology
  - 4.2.3.4. Others
- 4.2.4. By Region
  - 4.2.4.1. North America
  - 4.2.4.2. Europe
  - 4.2.4.3. Asia Pacific (APAC)
  - 4.2.4.4. Latin America (LATAM)
  - 4.2.4.5. Middle East and Africa (MEA)

5. North America Amniotic Products Market

5.1. Market Size & Forecast, 2019-2030
- 5.1.1. By Value (USD Million)
5.2. Market Share & Forecast
- 5.2.1. By Type
- 5.2.2. By End User
- 5.2.3. By Application
- 5.2.4. By Country
  - 5.2.4.1. United States
  - 5.2.4.1.1. By Type
  - 5.2.4.1.2. By End User
  - 5.2.4.1.3. By Application
  - 5.2.4.2. Canada
  - 5.2.4.2.1. By Type
  - 5.2.4.2.2. By End User
  - 5.2.4.2.3. By Application

6. Europe Amniotic Products Market

6.1. Market Size & Forecast, 2019-2030
- 6.1.1. By Value (USD Million)
6.2. Market Share & Forecast
- 6.2.1. By Type
- 6.2.2. By End User
- 6.2.3. By Application
- 6.2.4. By Country
  - 6.2.4.1. Germany
  - 6.2.4.1.1. By Type
  - 6.2.4.1.2. By End User
  - 6.2.4.1.3. By Application
  - 6.2.4.2. United Kingdom
  - 6.2.4.2.1. By Type
  - 6.2.4.2.2. By End User
  - 6.2.4.2.3. By Application
  - 6.2.4.3. Italy
  - 6.2.4.3.1. By Type
  - 6.2.4.3.2. By End User
  - 6.2.4.3.3. By Application
  - 6.2.4.4. France
  - 6.2.4.4.1. By Type
  - 6.2.4.4.2. By End User
  - 6.2.4.4.3. By Application
  - 6.2.4.5. Spain
  - 6.2.4.5.1. By Type
  - 6.2.4.5.2. By End User
  - 6.2.4.5.3. By Application
  - 6.2.4.6. Belgium
  - 6.2.4.6.1. By Type
  - 6.2.4.6.2. By End User
  - 6.2.4.6.3. By Application
  - 6.2.4.7. Russia
  - 6.2.4.7.1. By Type
  - 6.2.4.7.2. By End User
  - 6.2.4.7.3. By Application
  - 6.2.4.8. The Netherlands
  - 6.2.4.8.1. By Type
  - 6.2.4.8.2. By End User
  - 6.2.4.8.3. By Application
  - 6.2.4.9. Rest of Europe
  - 6.2.4.9.1. By Type
  - 6.2.4.9.2. By End User
  - 6.2.4.9.3. By Application

7. Asia Pacific Amniotic Products Market

7.1. Market Size & Forecast, 2019-2030
- 7.1.1. By Value (USD Million)
7.2. Market Share & Forecast
- 7.2.1. By Type
- 7.2.2. By End User
- 7.2.3. By Application
- 7.2.4. By Country
  - 7.2.4.1. China
  - 7.2.4.1.1. By Type
  - 7.2.4.1.2. By End User
  - 7.2.4.1.3. By Application
  - 7.2.4.2. India
  - 7.2.4.2.1. By Type
  - 7.2.4.2.2. By End User
  - 7.2.4.2.3. By Application
  - 7.2.4.3. Japan
  - 7.2.4.3.1. By Type
  - 7.2.4.3.2. By End User
  - 7.2.4.3.3. By Application
  - 7.2.4.4. South Korea
  - 7.2.4.4.1. By Type
  - 7.2.4.4.2. By End User
  - 7.2.4.4.3. By Application
  - 7.2.4.5. Australia & New Zealand
  - 7.2.4.5.1. By Type
  - 7.2.4.5.2. By End User
  - 7.2.4.5.3. By Application
  - 7.2.4.6. Indonesia
  - 7.2.4.6.1. By Type
  - 7.2.4.6.2. By End User
  - 7.2.4.6.3. By Application
  - 7.2.4.7. Malaysia
  - 7.2.4.7.1. By Type
  - 7.2.4.7.2. By End User
  - 7.2.4.7.3. By Application
  - 7.2.4.8. Singapore
  - 7.2.4.8.1. By Type
  - 7.2.4.8.2. By End User
  - 7.2.4.8.3. By Application
  - 7.2.4.9. Vietnam
  - 7.2.4.9.1. By Type
  - 7.2.4.9.2. By End User
  - 7.2.4.9.3. By Application
  - 7.2.4.10. Rest of APAC
  - 7.2.4.10.1. By Type
  - 7.2.4.10.2. By End User
  - 7.2.4.10.3. By Application

8. Latin America Amniotic Products Market

8.1. Market Size & Forecast, 2019-2030
- 8.1.1. By Value (USD Million)
8.2. Market Share & Forecast
- 8.2.1. By Type
- 8.2.2. By End User
- 8.2.3. By Application
- 8.2.4. By Country
  - 8.2.4.1. Brazil
  - 8.2.4.1.1. By Type
  - 8.2.4.1.2. By End User
  - 8.2.4.1.3. By Application
  - 8.2.4.2. Mexico
  - 8.2.4.2.1. By Type
  - 8.2.4.2.2. By End User
  - 8.2.4.2.3. By Application
  - 8.2.4.3. Argentina
  - 8.2.4.3.1. By Type
  - 8.2.4.3.2. By End User
  - 8.2.4.3.3. By Application
  - 8.2.4.4. Peru
  - 8.2.4.4.1. By Type
  - 8.2.4.4.2. By End User
  - 8.2.4.4.3. By Application
  - 8.2.4.5. Rest of LATAM
  - 8.2.4.5.1. By Type
  - 8.2.4.5.2. By End User
  - 8.2.4.5.3. By Application

9. Middle East & Africa Amniotic Products Market

9.1. Market Size & Forecast, 2019-2030
- 9.1.1. By Value (USD Million)
9.2. Market Share & Forecast
- 9.2.1. By Type
- 9.2.2. By End User
- 9.2.3. By Application
- 9.2.4. By Country
  - 9.2.4.1. Saudi Arabia
  - 9.2.4.1.1. By Type
  - 9.2.4.1.2. By End User
  - 9.2.4.1.3. By Application
  - 9.2.4.2. UAE
  - 9.2.4.2.1. By Type
  - 9.2.4.2.2. By End User
  - 9.2.4.2.3. By Application
  - 9.2.4.3. Qatar
  - 9.2.4.3.1. By Type
  - 9.2.4.3.2. By End User
  - 9.2.4.3.3. By Application
  - 9.2.4.4. Kuwait
  - 9.2.4.4.1. By Type
  - 9.2.4.4.2. By End User
  - 9.2.4.4.3. By Application
  - 9.2.4.5. South Africa
  - 9.2.4.5.1. By Type
  - 9.2.4.5.2. By End User
  - 9.2.4.5.3. By Application
  - 9.2.4.6. Nigeria
  - 9.2.4.6.1. By Type
  - 9.2.4.6.2. By End User
  - 9.2.4.6.3. By Application
  - 9.2.4.7. Algeria
  - 9.2.4.7.1. By Type
  - 9.2.4.7.2. By End User
  - 9.2.4.7.3. By Application
  - 9.2.4.8. Rest of MEA
  - 9.2.4.8.1. By Type
  - 9.2.4.8.2. By End User
  - 9.2.4.8.3. By Application

10. Competitive Landscape

10.1. List of Key Players and Their Offerings
10.2. Global Amniotic Products Market Share Analysis, 2023
10.3. Competitive Benchmarking, By Operating Parameters
10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Geopolitical Tension on Global Amniotic Products Market

12. Company Profiles (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

12.1. MiMedx Group
12.2. Organogenesis
12.3. Smith & Nephew
12.4. Integra LifeSciences
12.5. Amniox Medical
12.6. AmnioTech
12.7. Skye Biologics
12.8. Applied Biologics
12.9. TissueTech
12.10. Katena Products
12.11. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

14.1. Qualitative Research
- 14.1.1. Primary & Secondary Research
14.2. Quantitative Research
14.3. Market Breakdown & Data Triangulation
- 14.3.1. Secondary Research
- 14.3.2. Primary Research
14.4. Breakdown of Primary Research Respondents, By Region
14.5. Assumptions & Limitations